Featured Case Study
Newly appointed CFO and Independent Directors will help guide Alpha II’s next phase of growth and innovation
TALLAHASSEE, FL – July 30, 2024 – Alpha II, LLC (“Alpha II” or “the Company”), a leading provider of revenue cycle management (“RCM”) technology, today announced the appointment of John King and Julie Klapstein to its Board of Directors as new independent directors, effective immediately.
BOARD APPOINTMENTS
John King and Julie Klapstein are industry veterans with proven track records across multiple leading companies in the healthcare and information technology sectors.
John King has over three decades of experience in the healthcare space. Currently he serves as an Operating Partner at NexPhase Capital, a mid-market private equity firm focused on growth-oriented companies. In this role, he partners with management teams across NexPhase Capital’s software and healthcare portfolio to drive value creation and operational growth. Previously, John was the CEO of OmniSYS, a leading provider of medical billing, pharmacy workflow solutions, and patient engagement software. Before that, he served as the President of Standard Register Healthcare and held senior executive roles at McKesson and MedAssets. John previously served on the Board of Directors of Azalea Health, and currently sits on the Board of Directors of Meduit and Metz Culinary Management.
Julie Klapstein has over 35 years of experience in the healthcare sector and previously served on the boards of Oak Street Health and NextGen. Julie is founding CEO of Availity, an industry leader in optimizing the automated delivery of critical business and clinical information among healthcare stakeholders. During her decade-long tenure, Availity experienced rapid growth, expanding to provide a full claims clearinghouse and revenue cycle solution that served more than 16,000 provider offices and nearly every payor in the country. Prior to Availity, Julie was the CEO of Phycom, Inc. and held leadership roles at Revecore, Sunquest Information Systems, and GTE Health Systems. She serves on the Board of Directors of Amedisys and MultiPlan and is a Partner Advisor to a16z (Andreessen Horowitz).
“With a shared commitment to improving patient outcomes through the creation and adoption of best-in-class technology, we are excited to welcome both John and Julie to the Alpha II Board,” said Mark Carter, member of Alpha II’s Board of Directors and Managing Director at TA Associates. “Their combined industry leadership and operational expertise will enhance the strength of our Board, ensuring our continued success and further expansion.”
About Alpha II
Alpha II partners with medical groups, billing companies, PM systems, and clearinghouses across the country, raising the bar on automation and accuracy. Alpha II’s industry-standard and proprietary content, delivered via our workflow automation and claim scrubber solutions, ensures claims are paid correctly the first time. Whether fee-for-service, risk adjustment, or MIPS, Alpha II helps our clients boost staff efficiency and revenue. Learn more by visiting our websites, Alpha II and RCxRules.